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A B S T R A C T
Schinus terebinthifolius Raddi, commonly known as Brazilian peppertree, is a plant species widely used in
Brazilian traditional medicine for various purposes. The objective of this study was to assess the microbiological
quality, safety, chemical profile as well as antioxidant and antidiabetic potentials of different parts of S. ter-
ebinthifolius. Microbiological analysis of the methanolic extracts of the roots (MESR), stem bark (MESB) and
leaves (MESL) of S. terebinthifolius showed no microbial growth. The concentrations of phenolic compounds,
phenolic acids and flavonoids were determined by spectrophotometry. The phenolic compounds of the MESL
were identified by liquid chromatography coupled to a diode array detector and mass spectrometer (LC-DAD-
MS). The antioxidant activities of the extracts were analyzed by 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl
radical (DPPH%), 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) radical (ABTS%+), fluorescence recovery
after photobleaching (FRAP), reducing power, β-carotene bleaching and malondialdehyde (MDA) assays in
human erythrocytes. The antidiabetic properties of the extracts were demonstrated in vitro by their inhibition of
the α-glucosidase enzyme and their anti-glycation activity via fructose and glyoxal. After showing no acute
toxicity in vivo, MESL was able to lower postprandial glycemia after glucose overload in normoglycemic mice as
well as the water and feed intake, liver weight, glycemia and serum levels of glycated hemoglobin, aspartate
transaminase (AST) and alanine transaminase (ALT) in diabetic mice. Overall, S. terebinthifolius extracts showed
microbiological safety along with antioxidant and antidiabetic activities, likely mediated by its chemical con-
stituents, such as gallic acid, gallotannins and glycosylated flavonols.
1. Introduction
Schinus terebinthifolius Raddi, belonging to the Anacardiaceae fa-
mily, is a medicinal plant native to Brazil, commonly known as aroeira
or Brazilian peppertree. Previous studies have shown that S. ter-
ebinthifolius contains phenolic compounds with different biological ac-
tivities, as described below. In traditional medicine, this plant is used to
treat skin wounds and ulcers, tumors, diarrhea, arthritis as well as ur-
inary and respiratory tract infections (Brandão et al., 2006). Various
pharmacological activities have been described for this plant, including
antimicrobial (Silva et al., 2017a), antiulcerogenic (Carlini et al., 2010),
anticancer (Silva et al., 2017b), antihistamine (Nunes-Neto et al.,
2017), antihypertensive (Glória et al., 2017), antihyperalgesic
(Piccinelli et al., 2015), wound healing (Estevão et al., 2017), anti-in-
flammatory (Silva et al., 2017b) and antioxidant (Rocha et al., 2017)
activities in different models.
The increasing use of medicinal plants and/or natural products
highlights the need for studies on their efficacy and safety. Among the
main factors affecting these characteristics of natural products, their
microbiological quality stands out because the presence and quantity of
some species of microorganisms in the raw material may directly affect
the biological activity of the final product (Ratajczak et al., 2015). The
microbiological analysis of medicinal plants and/or non-sterile phar-
maceutical products aims to identify and quantify the microbial content
https://doi.org/10.1016/j.cbpc.2019.02.007
Received 7 December 2018; Received in revised form 14 February 2019; Accepted 15 February 2019
⁎ Corresponding author.
E-mail address: kelypicoli@gmail.com (K. de Picoli Souza).
Comparative Biochemistry and Physiology, Part C 220 (2019) 36–46
Available online 21 February 2019
1532-0456/ © 2019 Elsevier Inc. All rights reserved.
T
for ensuring the quality and safety of these products for human health
(Ratajczak et al., 2015).
Diabetes mellitus is among the diseases currently considered to be a
global epidemic, projected to grow among the world population and for
which new therapeutic alternatives are constantly sought (Wild et al.,
2004; Kharroubi and Darwish, 2015). It is a multifactorial disease
characterized by the development of metabolic disorders initially in-
volving the elevation of glycemia in response to poor insulin secretion
(type 1 diabetes) or cellular resistance to this hormone (type 2 diabetes)
(Kharroubi and Darwish, 2015).
Prolonged exposure to hyperglycemia is directly related to in-
creased levels of free radicals, which trigger or aggravate oxidative
stress. In combination, these changes lead to structural and functional
abnormalities of the endothelium and other tissues, thus contributing to
the development of cardiovascular diseases and other comorbidities in
diabetics (Node and Inoue, 2009; Singh et al., 2014; Kharroubi and
Darwish, 2015). Diabetic complications are aggravated by factors such
as postprandial hyperglycemia and the formation of advanced glycation
end products (AGEs) (Node and Inoue, 2009; Singh et al., 2014). Thus,
medicinal plants with antioxidant and antihyperglycemic properties
have become alternatives in the treatment of diabetes.
In this context, the objectives of this study were to determine the
quality and safety; identify the phytochemical constituents; and assess
the in vitro as well as in vivo antioxidant and antidiabetic properties of
different parts of S. terebinthifolius.
2. Material and methods
2.1. Plant material and extract preparation
The roots, stem bark and leaves of Schinus terebinthifolius Raddi were
collected after authorization from the SISBIO (Sistema de Autorização e
Informação em Biodiversidade; permit number 45365-1). The plant ma-
terial was collected in Dourados, Mato Grosso do Sul, Brazil, at geo-
graphic coordinates 22°11′43.7568″ S and 54°56′8.0916″ W. A voucher
specimen was deposited in the herbarium of the Federal University of
Grande Dourados, UFGD, Brazil (DDMS number 4889). The plant ma-
terials were dried in an air circulation oven at 30 ºC ± 5 ºC days,
pulverized in a knife mill and then maintained under intensive ma-
ceration in methanol P.A (99.8%). The filtrate was concentrated under
vacuum on a rotary evaporator at 45 °C and then lyophilized. The yields
of the methanolic extracts were approximately 2% for the roots
(MESR), 7% for the stem bark (MESB) and 13% for the leaves (MESL) of
S. terebinthifolius.
2.2. Microbiological analysis
To assess the microorganisms, 5 g of powder or 1 g of extract was
aseptically weighed and homogenized with 45 or 9mL of 0.5% sterile
peptone solution, respectively. Serial dilutions (1:10) of the sample
were prepared using the homogenate in the same sterile diluent. Two
independent assays were performed in duplicate, as described below.
2.2.1. Total mesophilic and psychrophilic microorganisms
Total mesophilic and psychrophilic microorganisms were quantified
according to NP-3788 (2002). Sample dilutions were incorporated
(1mL) into or plated (0.1 mL) in plate count agar (PCA) media in Petri
dishes. Colonies were counted after incubation in the Petri dishes at
30 °C for 72 h and at 15 °C for 5 days. The results were expressed as
colony forming units (CFU/g).
2.2.2. Molds and yeasts
Molds and yeasts were counted in DG18 growth media. Sample
dilutions (0.1 mL) were plated and incubated at 25 °C for 5 days ac-
cording to ISO-21527-2 (2008). The microbial counts were expressed as
CFU/g.
2.2.3. Sulfite-reducing Clostridium sp. spores
Sulfite-reducing Clostridium sp. spores were quantified according to
ISO-15213 (2003). For this purpose, sample dilutions were heated to
80 °C for 10min. Subsequently, 1 mL sample dilutions were added to
tubes containing iron sulfite agar. Then, another layer of agar was
added. After the media solidified, the tubes were incubated at 37 °C for
5 days. The formation of black colonies in test tubes was considered a
positive result. The results were expressed as CFU/g.
2.2.4. Salmonella sp
Salmonella sp. was detected using the immunodiffusion 1–2 test, as
described by the AOAC (1989). The results were obtained after pre-
enriching the sample in sterile buffered peptone water (1:10) incubated
at 37 °C for 24 h. The results were visually interpreted by monitoring
the development of an immunoband.
2.2.5. Escherichia coli
Escherichia coli was quantified using the SimPlate® Total Plate Count
BioControl kit according to the AOAC (2005). The culture medium
supplied was rehydrated in 9mL of distilled water, and the sample
dilutions (1 mL) were inoculated according to the manufacturer's in-
structions. The content was poured onto 84-well plates. The plates were
incubated at 37 °C for 24 h. E. coli was quantified by counting the
number of wells in which fluorescence was observed after exposure to
ultraviolet light at 365 nm. E. coli populations were defined based on
the number of positive wells, correlating the results with the SimPlate
conversion table and expressing them as CFU/g.
2.2.6. Staphylococcus aureus
To identify 0 (0.1 mL) were plated in Baird-Parker agar with egg
yolk tellurito emulsion, as described in NP-4400-1 (2002), for 48 h at
37 °C. The results were expressed as CFU/g.
2.2.7. Bacillus cereus
Bacillus cereus was counted according to ISO-7932 (2004) using
mannitol-egg yolk-polymyxin B agar (MYP). Sample dilutions (0.1 mL)
were plated and incubated at 30 °C for 24 h. Typical Bacillus cereus
colonies (with a dry and rough red-purple surface with a white pre-
cipitate) were counted, and the results were expressed as CFU/g.
2.3. Concentrations of phytochemical constituents
2.3.1. β-Carotene and lycopene
β-Carotene and lycopene were determined according to the method
of Barros et al. (2007). The extract (150mg) was vigorously shaken
with 10mL of an acetone–hexane mixture (4:6) for 1min and filtered
through Whatman No. 4 filter paper. The absorbance of the filtrate was
measured at 453, 505 and 663 nm. The contents of β-carotene and ly-
copene were calculated according to the following equations: β-car-
otene=0.216×A663–0.304×A505+ 0.452×A453; and lyco-
pene=−0.0458×A663+ 0.372×A505–0.0806×A453. The assays
were carried out in triplicate. The results were expressed as the mean
value± standard deviation as mg of carotenoid/g of extract.
2.3.2. Ascorbic acid
The ascorbic acid was determined according to the method of Barros
et al. (2007). The extract (100mg) was extracted with 10mL of 1%
metaphosphoric acid for 45min at room temperature and filtered
through Whatman No. 4 filter paper. The filtrate (1 mL) was mixed with
9mL of 2,6-dichlorophenolindophenol, and the absorbance was mea-
sured within 30min at 515 nm. The content of ascorbic acid was cal-
culated on the basis of the calibration curve of ascorbic acid
(0.020–0.12mg/mL). The assays were carried out in triplicate and ex-
pressed as mg of ascorbic acid/g of extract.
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2.3.3. Phenolic compounds
The phenolic compounds were determined according to the method
of Pinela et al. (2011). The extract concentrated at 0.625mg/mL
(250 μL) was mixed with 0.1% HCl or 2% HCl (4550 μL) in 95% ethanol
(250 μL). After 15min, the absorbance was measured at 280, 320 and
360 nm. The absorbance at 280 nm was used to estimate the total
phenolic content, while A320nm was used to determine the phenolic
acids and A360nm was used to determine the flavonoids. Gallic acid was
used to calculate the standard curve (50–500 μg/mL), and the results
were expressed as mg of gallic acid equivalents (GAE)/g of extract.
Caffeic acid was used to calculate the standard curve (50–500 μg/mL),
and the results were expressed as mg of caffeic acid equivalents (CAE)/
g of extract. Quercetin was used to calculate the standard curve
(30–300 μg/mL), and the results were expressed as mg of quercetin
equivalents (QE)/g of extract. The assays were carried out in triplicate.
2.3.4. Identification of the constituents by LC-DAD-MS
The MESL was analyzed by an ultra-fast liquid chromatograph
(Prominence, Shimadzu) coupled to a diode array detector (DAD) and
mass spectrometer (MicrOTOF-Q III, Bruker Daltonics, Billerica, MA,
USA). A Kinetex C18 column (2.6 μm, 150×2.1mm, Phenomenex)
was used with an injection volume, flow rate and oven temperature of
4 μL, 0.3mL/min and 50 °C, respectively. Acetonitrile (solvent B) and
water (solvent A), both containing 0.1% formic acid, were applied as
the mobile phase using the following gradient elution profile: 0–8min
at 3% B, 8–30min at 8–25% B, 30–60min at 25–80% B and 60–63min
at 80% B. For the mass spectrometry, nitrogen was used as the nebulizer
gas (4 bar), dry gas (9 L/min) and collisional gas, and the capillary
voltage was 2.5 kV. The extract was analyzed at a concentration of
1mg/mL in the negative and positive ion modes.
2.4. Antioxidant activity
2.4.1. DPPH% assay
The 2,2-diphenyl-1-picrylhydrazyl radical (DPPH%) scavenging ac-
tivity was evaluated according to the method described by Campos
et al. (2014). For this experiment, 200 μL of the extract was mixed with
1800 μL of 0.11mM DPPH% solution in 80% ethanol. The final con-
centrations of the extract ranged from 0.1 to 1000 μg/mL. The mixture
was incubated at room temperature in the dark for 30min. The ab-
sorbance was measured at 517 nm. Ascorbic acid and butylated hy-
droxytoluene (BHT) were used as reference antioxidants. As a control,
200 μL of the solvent (80% ethanol) was incubated with 1800 μL of the
DPPH% solution. Three independent experiments were performed in
triplicate. The percent inhibition was calculated from the control using
the following equation: capture activity of DPPH%
(%)= (1−Abssample/Abscontrol) × 100. The concentrations of the ex-
tracts resulting in 50% inhibition (IC50) were determined.
2.4.2. ABTS%+ assay
The 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) radical
(ABTS%+) scavenging activity was evaluated according to the method
described by Campos et al. (2015). For this experiment, the ABTS%+
was prepared from a mixture of 5mL of ABTS (7mM) and 88 μL of
potassium persulfate (140mM), which was incubated for 12–16 h at
room temperature in the dark. After this period, the ABTS%+ solution
was diluted in absolute ethanol until an absorbance of 0.70 ± 0.05 was
obtained at 734 nm. Then, 20 μL of the extract was added to 1980 μL of
the ABTS%+. The final concentrations of the extract ranged from 0.1 to
200 μg/mL. The mixture was incubated at room temperature in the dark
for 6min. The absorbance was evaluated at 734 nm. Ascorbic acid and
BHT were used as positive controls. As a control, 20 μL of the solvent
(80% ethanol) was incubated with 1980 μL of ABTS%+. Three in-
dependent experiments were performed in triplicate. The percentage of
ABTS%+ inhibition was calculated according to the following equation:
inhibition of ABTS%+ (%)= ((Abscontrol− Abssample)/Abscontrol) × 100.
The IC50 values were determined.
2.4.3. FRAP assay
The ferric reducing antioxidant power (FRAP) assay was evaluated
according to the method described by Pulido et al. (2000). For this
experiment, 100 μL of extract (1–1000 μg/mL) was mixed with 3mL of
FRAP reagent and 300 μL of distilled water. The FRAP reagent con-
tained 10mL of 10mmol/L 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) solu-
tion in 40mmol/L HCl, 10mL of 20mmol/L FeCl3%6H2O and 100mL of
0.3 mol/L acetate buffer (pH=3.6). The mixture was incubated at
room temperature in the dark for 20min. The absorbance was mea-
sured at 595 nm. Ascorbic acid was used as the reference antioxidant.
As a control, 100 μL of the solvent (80% ethanol) was incubated with
3mL of FRAP reagent and 300 μL of distilled water. Three independent
experiments were performed in triplicate. The half maximal effective
concentration (EC50) value was determined using the corresponding
regression equation.
2.4.4. Reducing power assay
The reducing power was evaluated according to the method de-
scribed by Berker et al. (2007). For this experiment, 1 mL of extract
(1–1000 μg/mL) was combined with 2.5mL of 0.2M phosphate buffer
(pH=6.6) and 2.5 mL of K3Fe(CN)6 solution (1%); the mixture was
incubated at 50 °C in a water bath for 20min. The incubated mixture
was let cool to room temperature, and 2.5 mL of 2,4,6-trichloroanisole
(TCA, 10%) was added. The solution was thoroughly mixed, an aliquot
of 2.5 mL was withdrawn, and 2.5 mL of water followed by 0.5mL of
FeCl3·6H2O solution (0.1%) was added so that the final volume was
5.5 mL. The absorbance was measured at 700 nm after 2min. Ascorbic
acid was used as the reference antioxidant. As a control, 1 mL of the
solvent (80% ethanol) was combined with 2.5mL of 0.2M phosphate
buffer (pH=6.6) and 2.5mL of K3Fe(CN)6 solution (1%); the mixture
was incubated at 50 °C in a water bath for 20min. The incubated
mixture was cooled to room temperature, and 2.5 mL of TCA (10%) was
added. The solution was thoroughly mixed, an aliquot of 2.5 mL was
withdrawn, and 2.5 mL of water followed by 0.5mL of FeCl3·6H2O
solution (0.1%) were added so that the final volume was 5.5 mL. Three
independent experiments were performed in triplicate. The EC50 value
was determined using the corresponding regression equation.
2.4.5. β-Carotene bleaching assay
β-Carotene bleaching inhibition was evaluated according to the
method described by Taga et al. (1984). For this experiment, 2 mg of β-
carotene was dissolved in 10mL of chloroform. The absorbance was
tested after adding 0.2mL of the solution to 5mL of chloroform and
then reading the absorbance of this solution at 470 nm. A reading be-
tween 0.6 and 0.9 indicated a workable concentration of β-carotene.
One milliliter of β-carotene chloroform solution was added with a
pipette to a boiling flask that contained 20mg of linoleic acid and
200mg of Tween 40. Chloroform was removed using a rotary eva-
porator at 40 °C, and 50mL of oxygenated distilled water was slowly
added to the flask with vigorous agitation to form an emulsion. Five
milliliters of the emulsion was added to 0.2mL of the extract in spec-
trophotometer tubes. A blank consisting of 2mg of linoleic acid, 20mg
of Tween 40 and 5mL of oxygenated water was used to bring the
spectrophotometer to zero. Tubes were shaken, and absorbance mea-
surements made at 470 nm immediately after the addition of the
emulsion to the extract as well as again after 60min. The tubes were
placed in an agitating water bath at 50 °C. The absorbance was mea-
sured at 470 nm. Butylated hydroxyanisol (BHA) was used as reference
antioxidant. As a control, 200 μL of the solvent (80% ethanol) was in-
cubated with 5mL of the emulsion. Three independent experiments
were performed in triplicate. The percent inhibition was calculated
from the control using the following equation: β-carotene bleaching
inhibition (%)= (1−Abssample/Abscontrol)× 100. The IC50 values were
determined.
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2.4.6. Dosage of malondialdehyde (MDA) assay
The antioxidant assay for the model of human erythrocytes was
evaluated according to the method described by Rocha et al. (2017).
Human erythrocyte assays were performed after receiving approval
from the Research Ethics Committee (Comitê de Ética em Pesquisa,
CEP) of the Federal University of Grande Dourados (Universidade
Federal da Grande Dourados, UFGD), Brazil (CEP process number
1.739.987). Peripheral blood from healthy donors was collected and
placed in tubes containing sodium citrate. The tubes were then cen-
trifuged at 2000×g for 5min, and the blood plasma as well as leuko-
cyte layer were discarded. The erythrocytes were washed three times
with 0.9% sodium chloride (NaCl) solution, and then, a 10% ery-
throcyte suspension in 0.9% NaCl solution was prepared for the assay.
The erythrocytes were pre-incubated at 37 °C for 30min with dif-
ferent concentrations of the extract (50–250 μg/mL). Ascorbic acid was
used as a positive control. Then, 2,2′-azobis(2-amidinopropane) dihy-
drochloride (AAPH) solution (50mM) was added, and the samples were
incubated at 37 °C for 180min with periodic homogenization. After this
time, the samples were centrifuged at 2000×g for 5min, and 0.5mL of
the supernatant was mixed with 1mL of 10 nmol thiobarbituric acid
(TBA) dissolved in 75mM potassium phosphate monobasic buffer at a
pH of 2.5. As a standard control, 0.5 mL of MDA solution (20 μM) was
incubated with 1mL of TBA. Samples were maintained at 96 °C for
45min. After cooling the solution, 4mL of n-butyl alcohol was added,
followed by centrifugation at 2000×g for 15min. The supernatants
from the samples were analyzed at 532 nm. Two independent experi-
ments were performed in duplicate. The MDA levels of the samples
were expressed in nmol/mL and were obtained by the following for-
mula: MDA (nmol/mL)=ABSsample× (20×220.32 ABSstandardMDA).
2.5. Antidiabetic properties
2.5.1. Alpha-glucosidase assay
The α-glucosidase assay was performed according to the method
described by Kazeem et al. (2013) using α-glucosidase from Sacchar-
omyces cerevisiae. The substrate solution p-nitrophenyl glucopyranoside
(pNPG) was prepared in 20mM phosphate buffer at a pH of 6.9. For this
experiment, 10 μL of α-glucosidase (1.0U/mL) was pre-incubated with
5 μL of the different concentrations of the extract (1–100 μg/mL) for
10min. Then, 5 μL of 3.0mM pNPG as a substrate dissolved in 20mM
phosphate buffer (pH=6.9) was then added to start the reaction. The
reaction mixture was incubated at 37 °C for 20min and stopped by
adding 200 μL of 0.1M Na2CO3. The α-glucosidase activity was de-
termined by measuring the yellow-colored paranitrophenol released
from pNPG at 405nm. A control was prepared using the same proce-
dure but replacing the extract with distilled water. Two independent
experiments were performed in triplicate. The results were expressed as
a percentage of the blank control. The percentage inhibition is calcu-
lated as % Inhibition= [(Abscontrol− Absextract)/Abscontrol]× 100. The
IC50 values were determined.
2.5.2. Anti-glycation assay
The anti-glycation activity was evaluated according to the method
described by Kiho et al. (2004). For this experiment, a solution of
0.1 mM fructose, 30mM glyoxal and 8mg/mL BSA was prepared in
phosphate buffer (0.2 M, pH=7.4, containing 3mM sodium azide as
an antimicrobial agent). Briefly, the 300 μL of reaction mixture was
composed of BSA (135 μL), fructose or glyoxal (135 μL), and extract
(30 μL). After this, the samples were incubated at 37 °C for 48 h or 72 h
(under sterile conditions). Then, each sample was examined for the
development of fluorescence (λex= 330 nm and λem=420 nm),
against blank on a microtiter plate reader. Quercetin was used as the
standard. A control was prepared using the same procedure but repla-
cing the extract with distilled water. Three independent experiments
were performed in triplicate. The percent inhibition of each extract was
calculated by using the following formula: %
inhibition= (1− fluorescencesample/fluorescencecontrol) × 100. The
IC50 values were determined.
2.6. In vivo studies
The experimental procedures with mice followed the standards of
the CONCEA (Conselho Nacional de Controle de Experimentação
Animal) and were approved by the CEUA/UFGD (Comissão de Ética
para Uso de Animais/Universidade Federal da Grande Dourados; pro-
cess number 37/2015). C57Bl/6 mice, 20–30 g and 16–24weeks of age,
were obtained from the UFGD Central Animal Facility, Mato Grosso do
Sul (MS), Brazil. The mice were housed in microisolators (5 mice per
microisolator) and kept under standard conditions (12 h light and 12 h
dark, 22 ± 2 °C), with access to water and feed ad libitum. Before
starting the experiment, the mice were acclimated to the laboratory
conditions. The dose administered for in vivo assays was selected based
on the acute toxicity study. The dose chosen was one tenth of the dose
considered to be safe.
2.6.1. Acute toxicity
The acute toxicity test was performed based on the protocols of the
Organization for Economic Cooperation and Development (OECD)
Guideline 425. On the first day, one C57Bl/6 mouse, after an 8 h fasting
period, received the dose of 2000mg/kg MESL by gavage. Subse-
quently, four other mice were subjected to 8 h of fasting and to a single
dose of 2000mg/kg MESL. The same procedure was subsequently re-
peated in another group of mice using the dose of 5000mg/kg MESL to
define the lethal dose for 50% of the mice (LD50). The mice were per-
iodically observed during the first 24 h and then once daily for 14 d,
with the body mass as well as water and food intake recorded. At the
end of the observation period, all mice were euthanized. The organs
(heart, lungs, liver and kidneys) were removed, weighed and macro-
scopically analyzed.
2.6.2. Glucose tolerance test
The glucose tolerance test (GTT) was performed according to the
method described by Lanjhiyana et al. (2011). For this purpose, adult
male C57Bl/6 mice were used. The mice fasted for 12 h and were di-
vided into the following four groups of five mice each: (I) Control:
water by gavage; (II) Glib: 10mg/kg glibenclamide by gavage; (III) Met:
100mg/kg metformin by gavage; and (IV) MESL: 200mg/kg metha-
nolic extract of the leaves of S. terebinthifolius by gavage. A glucose
solution (2 g/kg) was administered by gavage to all mice. Blood sam-
ples were collected from the caudal vein at time 0 (immediately before
glucose administration) and at 30, 60, 90, 120 and 180min after glu-
cose administration. Blood glucose levels were determined using the
AccuChek® active blood glucose meter.
2.6.3. Induction of diabetes and experimental procedures
Diabetes was induced in C57Bl/6 mice fasted for 12 h by a single
intraperitoneal injection of a 180mg/kg alloxan monohydrate solution.
The alloxan monohydrate solution was prepared with 0.9% NaCl. After
72 h, the serum glucose levels were determined using an AccuChek®
active blood glucose meter. Mice with fasting glycemia higher than
200mg/dL were considered diabetic.
The mice were divided into the following four groups of five ani-
mals: (I) ND-Control: normoglycemic mice treated with water; (II) D-
Control: diabetic mice treated with water; (III) D-Met: diabetic mice
treated with 100mg/kg metformin; and (IV) D-MESL: diabetic mice
treated with 200mg/kg methanolic extract of leaves of S. ter-
ebinthifolius. The treatments were administered by gavage for 28 d once
daily. After this period, the mice were euthanized, and the blood was
collected to assess biochemical and hematological parameters. The or-
gans (heart, liver and kidneys) were removed and weighed to calculate
the relative mass (g of organ per 100 g of body weight).
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2.7. Statistical analysis
The data are expressed as the mean ± standard error of the mean
(SEM). Analysis of variance (ANOVA) with the Student Newman Keuls
post-test was used for analysis and comparison between the experi-
mental groups. The area under the curve (AUC) was used for the GTT.
All statistical tests were performed using the software GraphPad Prism,
version 5.0. Data were considered significant when P < 0.05.
3. Results
3.1. Microbiological quality
Table 1 presents the microbiological evaluation of the powders and
MESR, MESB and MESL of S. terebinthifolius. The growth of mesophilic
microorganisms was observed in the powders of roots, stem bark and
leaves of S. terebinthifolius. Colonies of psychrophilic microorganisms,
molds and yeasts grew in the powders of roots and stem bark. No
growth of pathogenic microorganisms was observed, except in root
powder, where Bacillus cereus colonies grew. However, no microbial
growth occurred in the MESR, MESB and MESL of S. terebinthifolius.
3.2. Chemical constituents
Table 2 presents the contents of lipophilic and hydrophilic com-
pounds of the MESR, MESB and MESL. The hydrophilic compounds
stood out in all extracts, particularly phenolic compounds, which were
the main components. The MESB and MESL had the highest con-
centrations of phenolic acids and flavonoids.
3.3. Antioxidant activity
The antioxidant activities of the MESR, MESB and MESL were ob-
served in the DPPH%, ABTS%+, FRAP, reducing power, β-carotene
bleaching (Table 3) and MDA assays in human erythrocytes (Fig. 1).
Regarding the controls used, the IC50 DPPH% and ABTS%+ con-
centrations of the extracts were similar to those of ascorbic acid and
lower than those of BHT (Table 3). The EC50 values of the MESL in the
FRAP and reducing power assays were lower than those of the MESR
and MESB as well as approximately twice as high as those of ascorbic
acid (Table 3).
In the β-carotene bleaching assay (Table 3), the MESL had a lower
IC50 than the other extracts and (approximately 18 times) a higher IC50
than the antioxidant BHA. The IC50 of ascorbic acid was not detected in
this assay.
In human erythrocytes, the extracts reduced the oxidative stress
induced by the oxidant agent AAPH, as shown by the lower levels of
MDA generated (Fig. 1). At the concentrations tested (50 to 125 μg/
mL), the MESL promoted lower levels of MDA than the other extracts
and the control, ascorbic acid (Fig. 1).
3.4. In vitro antidiabetic properties
The antidiabetic properties of the MESR, MESB and MESL were
determined in vitro by the inhibition of the activity of the digestive
enzyme α-glucosidase and by the anti-glycation effect via fructose as
well as glyoxal (Table 4).
S. terebinthifolius extracts inhibited the activity of the enzyme α-
glucosidase, and the MESL showed a higher activity than the other
extracts, with an IC50 approximately twice as low as that of the other
extracts (Table 4). The MESL showed higher anti-glycation activity than
the other extracts, and the control quercetin had an IC50 (approximately
4 times) higher than fructose and similar to that of glyoxal (Table 4).
3.5. Chemical profile of the MESL
The chemical constituents were identified by their UV spectra, ac-
curate mass and fragment ions compared to published data in the lit-
erature, and some metabolites were confirmed by the injection of au-
thentic standards.
The identified constituents were O-glycosylated flavonols 4–7, 9–10,
12–14, 16–17, and 19–20; gallotannins 3, 8, 15, and 18; and gallic acid
1 along with its derivatives 2 and 11 (Fig. 2, Table 5). The main com-
pounds observed in the chromatogram (λ=270–330 nm) were 4-O-
Table 1
Microbiological evaluations (CFU/g) of the powders and the methanolic extracts of roots, stem bark and leaves from Schinus terebinthifolius Raddi.
Powder Extract
root stem bark leaves root stem bark leaves
Mesophilic microorganisms 1.90× 10−3 ± 0.001 1.43× 100 ± 0.11 5.17× 10−1 ± 0.01 absent absent absent
Psychrophyle microorganisms 4.70× 100 ± 1.54 4.73× 101 ± 7.70 absent absent absent absent
Molds and yeasts 1.93× 101 ± 1.85 4.95× 101 ± 7.70 absent absent absent absent
Clostridium sulfite reducer absent absent absent absent absent absent
Salmonella sp. absent absent absent absent absent absent
Escherichia coli absent absent absent absent absent absent
Staphylococcus aureus absent absent absent absent absent absent
Bacillus cereus 1.87× 101 ± 7.21 absent absent absent absent absent
The results are expressed as the mean ± SEM.
Table 2
Lipophilic and hydrophilic compounds of the methanolic extracts of roots (MESR), stem bark (MESB) and leaves (MESL) from Schinus terebinthifolius Raddi.
Compounds MESR MESB MESL
Lipophilic
β-Carotene (mg/g extract) 0.054± 0.006a 0.313±0.027b 1.455± 0.009c
Lycopene (mg/g extract) 0.029± 0.002a 0.049±0.008b 0.013± 0.002a
Hydrophilic
Ascorbic acid (mg/g extract) 0.115± 0.002a 0.123±0.002a 0.070± 0.003b
Phenolics (mg GAE/g extract) 300.42± 9.30a 274.94± 8.09a 446.48± 28.93b
Phenolic acids (mg CAE/g extract) 24.49± 1.80a 49.12±1.30b 52.95± 4.23b
Flavonoids (mg QE/g extract) 21.16± 2.65a 55.72±1.56b 57.78± 3.79b
The results are expressed as the mean ± SEM.
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methyl gallic acid 2 and penta-O-galloyl hexoside 15 (Fig. 2).
The peaks 1, 2 and 11 showed a λmax≈ 280 nm, and gallic acid (1)
was confirmed by a standard. Compound 2 exhibited intense ions at m/
z 185.0451 [M+H]+ and 183.0304 [M-H]−, confirming the molecular
formula C8H8O5 and an additional methyl on the gallic acid. The
fragment ion at m/z 153.0186 (C7H5O4+, error= 2.4 ppm) indicated
the loss of a methanol molecule (32 u), which is a diagnostic ion for a
methyl group at C-4 (Liao et al., 2013) because the losses of radical
methyl and, subsequently, CO2 molecules suggest a methyl substituent
at C-3 or C-7 (carboxyl) (Kumar et al., 2015; Ersan et al., 2016). For
compound 11, the ion m/z 335.0412 [M-H]− (C15H11O9−,
error= 2.8 ppm) yielded the fragment ion at m/z 183 by the loss of a
galloyl unit, which is relative to a methylated galloyl, as reported by
Ersan et al. (2016). Thus, compounds 1, 2 and 11 were identified as
gallic acid, 4-O-methyl gallic acid and methyl digallate, respectively.
The substances 3, 8, 15 and 18 showed absorption bands with a
λmax similar to gallic acid. In addition, they revealed consecutive losses
of galloyl units (152 u) and/or losses of a galloyl unit and subsequently
a water molecule (170 u). They also showed the typical fragment ion at
m/z 169 [gallic acid-H]− and the absence of an ion at m/z 301, which
confirmed the identification of gallotannins (Ersan et al., 2016; Muccilli
et al., 2017). For example, compound 15 exhibited an intense ion at m/z
939.1102 [M-H]− (compatible with C41H31O26−) and yielded fragment
ions by the losses of galloyl units such as m/z 787 [M-H-galloyl]−, 769
[M-H-galloyl-H2O]−, 617 [M-H-2× galloyl-H2O]−, 599 [M-H– 2×
galloyl-2× H2O]−, 447 [M-H-3× galloyl-2× H2O]−, and 277 [M-H-
4× galloyl-3× H2O]−; thus, they confirmed the identification of penta-
O-galloyl hexoside, a compound already described for S. terebinthifolius
(Hayashi et al., 1989). Additionally, the substances 3, 8 and 18 were
identified as tri-O-galloyl hexoside, tetra-O-galloyl hexoside and hexa-
O-galloyl hexoside, respectively. All data agreed with the published
data for these compounds (Abu-Reidah et al., 2015; Kumar et al., 2015;
Ersan et al., 2016; Muccilli et al., 2017).
Compounds 4–7, 9–10, 12–14, 16–17 and 19–20 revealed UV
spectra similar to flavonol (λmax≈ 265 and 350 nm) (Ersan et al.,
2016). The substances 4–7, 9 and 19 yielded a main fragment ion at m/z
316, while compounds 10, 12, and 16 as well as 14, 17, and 20 yielded
fragment ions at m/z 284 and 300 in negative ion mode, which are
compatible with the aglycones myricetin (C15H8O8−), quercetin
(C15H8O7-%) and kaempferol (C15H8O6-%). The losses of 132, 146 and
162 u confirmed the sugars pentosyl, deoxyhexosyl and hexosyl, re-
spectively. All of the fragment ions were similar to data reported in the
literature (March et al., 2006; Liao et al., 2013; Ersan et al., 2016).
3.6. Acute toxicity
Table 6 presents the anthropometric parameters of mice treated
with the MESL in the acute toxicity test. No mortality was observed
during the experimental period after administering doses of 2000 and
5000mg/kg MESL. The mice treated with 2000mg/kg MESL showed
no changes in the anthropometric parameters (Table 6). However, the
mice treated with 5000mg/kg MESL showed decreased body mass,
increased water and feed intake and a slight decrease in kidney weight
Table 3
Antioxidant activities of the methanolic extract of root (MESR), stem bark (MESB) and leaves (MESL) from Schinus terebinthifolius Raddi.
Sample DPPH% ABTS%+ FRAP Reducing power β-carotene bleaching
IC50 (μg/mL) EC50 (μg/mL) IC50 (μg/mL)
Ascorbic acid 3.06 ± 0.16 2.31 ± 0.05 33.58 ± 0.80 42.97 ± 0.70 ND
Lipophilic antioxidant 37.45 ± 3.09 20.87 ± 1.82 – – 3.80 ± 0.10
MESR 6.31 ± 0.06 3.25 ± 0.22 85.11 ± 4.27 133.52 ± 1.11 176.56 ± 21.30
MESB 4.50 ± 0.11 4.45 ± 0.49 116.33 ± 3.53 169.76 ± 1.90 220.37 ± 35.99
MESL 4.17 ± 0.69 3.83 ± 0.36 68.78 ± 2.01 95.30 ± 3.64 67.06 ± 3.78
Lipophilic antioxidant: BHT for DPPH% and ABTS%+; BHA for the β-carotene bleaching assay. ND: not detected. -: unrealized. The results are expressed as the
mean ± SEM.
Fig. 1. Antioxidant activities of the methanolic extracts of the roots (MESR), stem bark (MESB) and leaves (MESL) from Schinus terebinthifolius Raddi in human
erythrocytes with AAPH-induced oxidative stress. MDA: malondialdehyde. The values shown are the mean ± SEM. ***P < 0.001 versus the control (NaCl 0.9%).
Table 4
α-Glucosidase inhibition and anti-glycation activity by the methanolic extracts




IC50 (μg/mL) IC50 (μg/mL)
Quercetin – 0.32 ± 0.01 35.12 ± 0.27
MESR 31.16 ± 0.17 3.16 ± 0.01 116.18 ± 2.23
MESB 33.01 ± 1.65 1.54 ± 0.03 98.43 ± 0.48
MESL 16.13 ± 0.49 1.29 ± 0.01 32.40 ± 0.84
The results are expressed as the mean ± SEM.
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when compared with the other groups. Thus, considering the data to-
gether, the LD50 of the MESL was estimated as higher than 5000mg/kg,
and the in vivo assays proceeded with a dose of 200mg/kg, that is, 10
times lower than the dose considered safe in this study.
3.7. In vivo antidiabetic properties
3.7.1. Oral glucose tolerance test
Fig. 3 shows the effects of the MESL on the glycemia of normogly-
cemic mice after oral glucose overload. The MESL reduced the glycemic
peak at 30min by 35 ± 5% (Fig. 3A) as well as the postprandial gly-
cemia by 24 ± 6%, as assessed by the AUC up to 180min (Fig. 3B)
when compared with the control group. Furthermore, the effects of the
MESL on the glycemia of normoglycemic mice were similar to those
induced by glibenclamide and weaker than those of metformin.
3.7.2. In vivo antidiabetic activity
Table 7 presents the anthropometric and biochemical parameters of
normoglycemic (ND-Control) and diabetic C57Bl/6 mice treated with
water (D-Control), metformin (D-Met) and the MESL (D-MESL). The
evolution of the glycemic parameters of all the experimental groups are
represented in Table S1.
Diabetic mice (D-Control) showed higher water and feed intake,
glycemia, glycated hemoglobin, AST and ALT liver enzymes and liver
weight than the ND-Control group (Table 7). Diabetic mice treated with
the MESL (D-MESL) showed decreased water intake, and the other
anthropometric and biochemical parameters were normal (Table 7). In
all experimental groups, the organs (liver, kidneys, heart and pancreas)
Fig. 2. Chromatographic profile at 270–330 nm of the methanolic extract of Schinus terebinthifolius Raddi leaves (MESL).
Table 5
Identification of the constituents from the MESL of Schinus terebinthifolius by LC-DAD-MS/MS.
Peak RT (min) Compound UV (nm) FM Negative mode m/z Positive mode m/z
MS [M-H]− (ppmer) MS/MS MS [M+H]+
(ppmer)
MS/MS
1 2.4 Gallic acid⁎ 270 C7H6O5 169.0146 (2.1) – 171.0295 (4.0) –
2 8.2 4-O-methyl gallic acid 271 C8H8O5 183.0304 (2.8) – 185.0451 (3.6) 153
3 19.5 Tri-O-galloyl hexoside 278 C27H24O18 635.0873 (2.7) 465, 313, 169 659.0883Na (4.3) 153
4 21.4 Myricetin O-hexoside 265, 365 C21H20O13 479.0819 (2.6) 316 481.0993 (3.3) 319
5 21.6 Myricetin O-hexosyl-
deoxyhexoside
265, 355 C27H30O17 625.1396 (2.3) 479, 316 627.1564 (1.3) 481, 319
6 21.8 Myricetin O-hexosyl-
deoxyhexoside
265, 355 C27H30O17 625.1416 (1.0) 479, 316 627.1585 (4.6) 481, 319
7 22.3 Myricetin O-pentoside 265, 353 C20H18O12 449.0721 (1.0) 316 451.0888 (3.7) 319, 273, 245, 167
8 23.2 Tetra-O-galloyl hexoside 278 C34H28O22 787.1000 (0.1) 635, 617, 465, 169 811.0966Na (0.2) –
9 23.5 Myricetin O-deoxyhexoside 265, 350 C21H20O12 463.0882 (1.3) 316, 271 465.1048 (4.3) 319, 245, 217, 153
10 23.8 Quercetin O-hexoside 265, 353 C21H20O12 463.0881 (0.2) 300 465.1044 (3.6) 303
11 24.4 Methyl digallate 275 C15H12O9 335.0412 (1.1) 183 337.0568 (4.2) 153
12 25.1 Quercetin O-pentoside 263, 355 C20H18O11 433.0775 (0.4) 300, 271 435.0911 (2.5) 303
13 25.5 Quercetin O-pentoside 263, 355 C20H18O11 433.0772 (0.9) 300, 271 435.0938 (3.7) 303
14 25.6 Kaempferol O-hexoside 263, 350 C21H20O11 447.0950 (3.9) 284 449.1086 (1.8) 287
15 25.7 Penta-O-galloyl hexoside 279 C41H32O26 939.1102 (0.8) 787, 769, 617, 599, 447, 277,
169, 125
963.1107Na (3.4) 793, 641, 471, 301,
153
16 26.5 Quercetin O-deoxyhexoside 260, 350 C21H20O11 447.0943 (2.2) 300, 271, 255 449.1070 (1.9) 303
17 27.1 Kaempferol O-pentoside 263, 350 C20H34O9 417.2125 (1.3) 284 419.0991 (4.5) 287
18 27.9 Hexa-O-galloyl hexoside 280 C48H36O30 1091.1212 (0.6) 921, 769, 617, 393 1115.1175Na (0.7) –




C28H24O16 615.1003 (1.9) 317 617.1145 (1.2) –
20 28.9 Kaempferol O-deoxyhexoside 263, 350 C21H20O10 431.0989 (1.1) 284 433.1121 (2.0) 287
21 64.0 Unknown 300 C24H36O3 371.2581 (2.8) 327 373.2747 (2.7) 355
(ppmer): Error in ppm; Na: [M+Na]+; ⁎: confirmed by an authentic standard.
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were evaluated macroscopically and no presented changes in respect to
their color, consistency, size or presence of lesions e tumors. The effects
of the MESL on the parameters assessed in diabetic mice were stronger
than those triggered by the reference drug metformin at the con-
centrations tested (Table 7).
4. Discussion
Scientific knowledge about the biological activities of medicinal
plants may stimulate the development of new therapeutic alternatives.
Schinus terebinthifolius Raddi is a medicinal plant commonly used for
various purposes, and it is included in the list of medicinal plants in-
dicated by the Brazilian public health system (RENISUS, 2009).
Natural products are subjected to microbiological and toxicological
assessments to determine their safety. The presence of microorganisms
in plants results from different soil, air and water contaminants. Many
of these contaminants in non-sterile pharmaceuticals can alter their
therapeutic properties and damage health (Ratajczak et al., 2015). The
presence of the pathogenic microorganism Bacillus cereus exclusively in
the S. terebinthifolius root powder and the absence of microbial growth
in the extracts of all plant parts may indicate the microbiological safety
of these plant materials, characterizing them as high-quality natural
products (Santos et al., 2018). Furthermore, the absence of toxicity
signs in the acute toxicity test supports the pharmacological potential of
S. terebinthifolius.
Plant extracts have a set of different bioactive constituents, and
phenolic compounds were the major constituents hydrophilic of the S.
terebinthifolius extracts. However, different parts of the same plant may
have different composition of phytochemical constituents (Singh et al.,
2015). Among the extracts, the MESL had the highest content of phe-
nolic compounds and β-Carotene (lipophilic compound) as well as the
highest efficacy for the biological activities tested. Phenolic compounds
are known to act as antioxidants, especially for their ability to donate
hydrogen or electrons, thereby inhibiting the action of reactive oxygen
species (ROS) and lipid peroxidation reactions (Rice-Evans et al., 1997).
The free radical scavenging observed in this study indicates the
potential of these extracts to donate electrons to stabilize radical mo-
lecules. This ability is crucial because the excess of free radicals is one
of the main factors that causes and worsens pathological conditions
such as cancer (Reuter et al., 2010), obesity (Fernandez-Sanchez et al.,
2011), cardiovascular diseases (Csányi and Miller, 2014) and diabetes
(Giacco and Brownlee, 2010).
The hydroxyl radical (OH%) is one of the most reactive molecules for
which no endogenous defense system is available (Lipinski, 2011). OH%
is formed in Fenton's reaction, in which ferrous iron (Fe2+) is oxidized
to ferric iron (Fe3+) by hydrogen peroxide (H2O2) (Winterbourn,
1995). S. terebinthifolius extracts showed a lower iron reducing power
than the ascorbic acid standard, and therefore, they can avoid OH%
generation. Some antioxidants with a high iron reducing power may
have pro-oxidant characteristics (Chobot and Hadacek, 2011).
In biological systems, membrane lipids are targets of OH%, which is
able to oxidize polyunsaturated fatty acids and form lipid hydroper-
oxides (Ayala et al., 2014). The inhibition of the oxidation of the lipid
substrate β-carotene by S. terebinthifolius extracts may indicate the
ability to prevent changes in membrane structure and permeability
resulting from lipid peroxidation.
Those membrane changes may result from the toxic byproducts of
lipid peroxidation, such as MDA (Grotto et al., 2009). In human ery-
throcytes under induced oxidative stress, S. terebinthifolius extracts re-
duced the MDA levels generated, with the MESL showing the highest
effect.
Oxidative stress affects virtually all physiological systems and is
associated with the development of various diseases, including diabetes
(Giacco and Brownlee, 2010). Increased glycemia also increases free
radical production, primarily through protein glycation (Singh et al.,
2014). Glycated hemoglobin and fructosamine are examples of Ama-
dori products that form AGEs (Gillery, 2014). The formation of AGEs is
closely related to the development of diabetic complications (Node and
Inoue, 2009; Singh et al., 2014); therefore, glycemic control is critical
to prevent such events (Skyler, 2004). The binding of AGEs to their
Table 6
Anthropometric parameters of C57Bl/6 normal mice in the acute toxicity test






Δ BW (%) −0.31 ± 1.30a −2.78 ± 1.62ab −5.73 ± 1.11b
Water intake (mL/day) 6.25 ± 0.45a 6.02 ± 0.52a 12.36 ± 0.77b
Food intake (g/day) 3.84 ± 0.21a 5.14 ± 0.31ab 6.30 ± 0.65b
Liver (g/100 g of BW) 3.93 ± 0.10 3.59 ± 0.09 3.75 ± 0.14
Lung (g/100 g of BW) 0.60 ± 0.02 0.68 ± 0.09 0.62 ± 0.02
Kidney (g/100 g of BW) 1.06 ± 0.02ab 1.11 ± 0.06a 0.95 ± 0.02b
Heart (g/100 g of BW) 0.56 ± 0.03 0.57 ± 0.04 0.54 ± 0.02
Δ BW (%): variation in the % between the final and initial body weight. The
values shown are the mean ± SEM. N=5 mice per group. Different letters
indicate statistically significant differences.
Fig. 3. (A) Glycemia and (B) AUC obtained in the glucose tolerance test in C57Bl/6 normoglycemic mice that received a single oral dose of the following: water
(Control), glibenclamide (Glib), 100mg/kg metformin (Met) and the methanolic extract of leaves from Schinus terebinthifolius Raddi at 200mg/kg (MESL). Values
shown are the mean ± SEM. N=5 mice per group. Different letters indicate statistically significant differences.
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receptors (RAGEs) leads to cellular dysfunction, which includes the
increased production of inflammatory cytokines, such as interleukin 1
and 6 (IL-1 and IL-6), growth factor I (GF-1) and tumor necrosis factor
alpha (TNFα) (Singh et al., 2014). AGEs accumulate in most target
organs of diabetes, such as the kidneys and retina (Singh et al., 2014).
The anti-glycation activity of the extracts was shown by the decreased
glycation via fructose and glyoxal, and the MESL had a higher anti-
glycation activity than the other extracts. Diabetic animals treated with
the MESL showed reduced levels of glycated hemoglobin.
Oxidative stress, hyperglycemia and diabetes control have been
related to the action of various natural substances, particularly phenolic
compounds (Rice-Evans et al., 1997; Xie and Chen, 2013). Gallic acid
and its derivatives, gallotannins and glycosylated flavonols of myr-
icetin, quercetin and kaempferol were identified in the MESL. In other
studies, these phenolic compounds have been related to antioxidant
action and glycemic control. Gallic acid and its derivatives have been
described as oxidative stress reducers (Abdel-Moneim et al., 2017;
Karimi-Khouzani et al., 2017; Omobowale et al., 2017). Tannins have
antioxidant properties, although they primarily maintain glycemic le-
vels by inhibiting α-glucosidase (Lee et al., 2017; Muccilli et al., 2017).
Studies indicate the effect of glycosylated quercetin on glycemic re-
duction by protecting pancreatic cells or improving insulin sensitivity
(Yan et al., 2015). Decreased fasting glycemia and the serum levels of
glycated hemoglobin have already been observed in vivo after the ad-
ministration of glycosylated kaempferol (Zang et al., 2015). Other
studies observed that glycosylated flavonols are also capable of in-
hibiting α-glycosidase activity (Sun et al., 2014) and glycating proteins
in vitro (Kim et al., 2004). In addition to the above effects, the MESL
reduced postprandial glycemia in normoglycemic mice after glucose
overload, thus indicating their ability to change mechanisms of gly-
cemic control.
The mechanisms currently used to control hyperglycemia include
the inhibition of the activity of the digestive enzyme α-glucosidase,
which regulates the uptake of glucose generated from starch (van de
Laar, 2008). Glucosidase inhibitors, such as acarbose, miglitol and vo-
glibose, act as enzymatic α-glucosidase antagonists, reducing intestinal
glucose uptake and postprandial glycemia, albeit causing side effects
such as flatulence, diarrhea and abdominal pain (van de Laar et al.,
2005). S. terebinthifolius extracts, especially the MESL, inhibited α-gly-
cosidase activity, and the inhibition of this enzyme has been a pro-
mising target for the development of antidiabetic drugs (van de Laar,
2008).
The classic symptoms of chronic hyperglycemia, polydipsia and
polyphagia, which reflect homeostatic imbalances in diabetes
(Fournier, 2000; American Diabetes Association, 2009), were partly or
fully reversed with the administration of the MESL to diabetic mice.
Feed intake normalization in diabetic mice treated with the MESL
correlates positively with the decrease in glucose and glycated he-
moglobin levels observed in these animals.
Similarly, hepatomegaly as well as the elevated AST and ALT levels
of diabetic mice, likely related to the excessive glycogen accumulation
in hepatocytes (Sarkhy et al., 2017), were fully reversed in diabetic
mice treated with the MESL, which showed normalization of the liver
weight as well as the liver enzymes AST and ALT, similarly to mice
treated with metformin.
Overall, the data showed that S. terebinthifolius extracts are micro-
biologically safe and these extracts, particularly the MESL, help control
oxidative stress, postprandial hyperglycemia and the main symptoms of
diabetes. This action is most likely mediated by their chemical con-
stituents, such as gallic acid, gallotannins and glycosylated flavonols.
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